Search Results

project, licensed to AstraZeneca (Saphnelo™ Anifrolumab) that has just received FDA approval for systemic lupus

p38 signaling responses we are studying how atypical p38 controls the onset and pathogenesis of acute lung

David Hodson Topics Covered: LUXendin probes for GLP-1R labeling across imaging modalities daLUXendin

receptors 06:30 When the field debated whether opioid receptors were even proteins 11:31 The "dumb luck

Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for

examine the assay principle, validation strategy, and performance across reference antagonists and agonis Lucía degenerative, metabolic, immunological… around a third of the drugs in clinical use are GPCR ligands Lucía

Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Stefan Diethelm , Luboš

This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived

From that point on, Paul was hooked and has since studied receptor function in human physiology, receptor

Inspire young scientists to work on GPCRs It’s been a privilege to chat with so many GPCR scientists since